Tectonic Therapeutic, Inc.
- TECX
- NASDAQ
- Biotechnology
- GPCR-targeted Biologics
- Therapeutic Proteins/Antibodies
$20.65
Today −3.05%Quote Oct 16, 2026, 08:00 PM UTC
−24.11%over the last month
Max drawdown −24.1%From 1-month high −24.1%3 months −35.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$403.7M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$62.33
+201.8% from here
Floor
$20.06
2.9% below price
Where the price sits
5 analysts
Analyst range, low to high
$26.00$81.00
- Price $20.65
- Resistance $20.82
- Consensus $62.33
The price is right under resistance. Analysts' average target sits about 202% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TECXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
60